Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats

  • Authors:
    • Takahiro Ueno
    • Noboru Fukuda
    • Hiroki Nagase
    • Akiko Tsunemi
    • Kazunobu Tahira
    • Taro Matsumoto
    • Junko Hiraoka-Yamamoto
    • Katsumi Ikeda
    • Masako Mitsumata
    • Yuichi Sato
    • Masayoshi Soma
    • Koichi Matsumoto
    • Yukio Yamori
  • View Affiliations

  • Published online on: March 1, 2009     https://doi.org/10.3892/ijmm_00000133
  • Pages: 313-320
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We investigated lipid and lipoprotein abnormalities in SHRSP fatty rats as a new animal model of metabolic syndrome. We examined differentially expressed genes in the liver, one of the major tissues contributing to lipid metabolism. Using gel filtration high performance liquid chromatography, increased cholesterol concentrations of small particle size low-density lipoprotein (LDL) fractions were observed in SHRSP fatty rats, whereas the Zucker Fatty strain did not show a similar elevation of cholesterol content. Existence of apolipoprotein B in these fractions was confirmed by Western blotting. The small particle size of the LDL fractions was significantly decreased by a 4-week fenofibrate treatment. Microarray analysis identified seventeen genes that were significantly upregulated and ten that were significantly decreased in liver tissues of SHRSP fatty rats compared with levels in SHRSP rats. Stearoyl-coenzyme A desaturase 1, fatty acid synthase, ATP citrate lyase, and sterol regulatory element binding factor 1 genes were among the upregulated genes. These findings suggest that SHRSP fatty rats carry small dense LDL like particles which is a common lipid abnormality in the metabolic syndrome. Three of ten genes upregulated in liver tissues of SHRSP fatty rats play a role in this metabolic abnormality and are a therapeutic target of this metabolic syndrome.

Related Articles

Journal Cover

March 2009
Volume 23 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ueno T, Fukuda N, Nagase H, Tsunemi A, Tahira K, Matsumoto T, Hiraoka-Yamamoto J, Ikeda K, Mitsumata M, Sato Y, Sato Y, et al: Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats. Int J Mol Med 23: 313-320, 2009
APA
Ueno, T., Fukuda, N., Nagase, H., Tsunemi, A., Tahira, K., Matsumoto, T. ... Yamori, Y. (2009). Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats. International Journal of Molecular Medicine, 23, 313-320. https://doi.org/10.3892/ijmm_00000133
MLA
Ueno, T., Fukuda, N., Nagase, H., Tsunemi, A., Tahira, K., Matsumoto, T., Hiraoka-Yamamoto, J., Ikeda, K., Mitsumata, M., Sato, Y., Soma, M., Matsumoto, K., Yamori, Y."Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats". International Journal of Molecular Medicine 23.3 (2009): 313-320.
Chicago
Ueno, T., Fukuda, N., Nagase, H., Tsunemi, A., Tahira, K., Matsumoto, T., Hiraoka-Yamamoto, J., Ikeda, K., Mitsumata, M., Sato, Y., Soma, M., Matsumoto, K., Yamori, Y."Atherogenic dyslipidemia and altered hepatic gene expression in SHRSP.Z-Leprfa/IzmDmcr rats". International Journal of Molecular Medicine 23, no. 3 (2009): 313-320. https://doi.org/10.3892/ijmm_00000133